Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph L Witztum

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
The Journal of Clinical Investigation|August 3, 2005
You are right too!Joseph L Witztum
Circulation Research|August 1, 2015
CEP Is an Important and Ubiquitous Oxidation Specific Epitope Recognized by Innate Pattern Recognition ReceptorsJoseph L Witztum
The Journal of Clinical Investigation|March 20, 2002
Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?Joseph L Witztum
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2010
Oxidized low-density lipoprotein and atherosclerosisDaniel Steinberg, Joseph L Witztum
Journal of the American College of Cardiology|December 31, 2002
Shifting the diagnosis and treatment of atherosclerosis to children and young adults: a new paradigm for the 21st centurySotirios Tsimikas, Joseph L Witztum
Circulation|May 1, 2002
Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?Daniel Steinberg, Joseph L Witztum
Current Opinion in Lipidology|July 9, 2008
The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicitySotirios Tsimikas, Joseph L Witztum
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2009
Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levelsDaniel Steinberg, Joseph L Witztum
Nature Reviews. Cardiology|October 17, 2023
Oxidized phospholipids in cardiovascular diseaseSotirios Tsimikas, Joseph L Witztum
Journal of Lipid Research|February 4, 2016
Lipoprotein (a): Coming of Age at LastJoseph L Witztum, Henry N Ginsberg
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Clinical Investigation|August 3, 2005
You are right too!Joseph L Witztum
Circulation Research|August 1, 2015
CEP Is an Important and Ubiquitous Oxidation Specific Epitope Recognized by Innate Pattern Recognition ReceptorsJoseph L Witztum
The Journal of Clinical Investigation|March 20, 2002
Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?Joseph L Witztum
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2010
Oxidized low-density lipoprotein and atherosclerosisDaniel Steinberg, Joseph L Witztum
Journal of the American College of Cardiology|December 31, 2002
Shifting the diagnosis and treatment of atherosclerosis to children and young adults: a new paradigm for the 21st centurySotirios Tsimikas, Joseph L Witztum
Circulation|May 1, 2002
Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?Daniel Steinberg, Joseph L Witztum
Current Opinion in Lipidology|July 9, 2008
The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicitySotirios Tsimikas, Joseph L Witztum
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2009
Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levelsDaniel Steinberg, Joseph L Witztum
Nature Reviews. Cardiology|October 17, 2023
Oxidized phospholipids in cardiovascular diseaseSotirios Tsimikas, Joseph L Witztum
Journal of Lipid Research|February 4, 2016
Lipoprotein (a): Coming of Age at LastJoseph L Witztum, Henry N Ginsberg
Pageof 29